These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
152 related items for PubMed ID: 3724656
21. [Penicillamine and other therapeutic methods in the treatment of Wilson's disease]. Czlonkowska A, Czlonkowski A. Neurol Neurochir Pol; 1975; 9(3):401-6. PubMed ID: 1097955 [No Abstract] [Full Text] [Related]
22. Treatment of Wilson's disease with triethylene tetramine hydrochloride (Trientine). Dubois RS, Rodgerson DO, Hambidge KM. J Pediatr Gastroenterol Nutr; 1990 Jan; 10(1):77-81. PubMed ID: 2324883 [Abstract] [Full Text] [Related]
23. [Pathogenesis and treatment of Wilson's disease]. Nagy J, Vincze Z, Folhoffer A, Horváth A, Csák T, Zelkó R. Acta Pharm Hung; 2003 Jan; 73(4):237-41. PubMed ID: 15279036 [Abstract] [Full Text] [Related]
24. Two male patients with Wilson's disease treated using trientine and iron reduction therapy. Hayashi H, Ueno T, Yano M, Okada T, Mabuchi H. J Gastroenterol Hepatol; 2005 Oct; 20(10):1627-8. PubMed ID: 16174091 [No Abstract] [Full Text] [Related]
25. Treatment of Wilson's disease with trientine (triethylene tetramine) dihydrochloride. Walshe JM. Lancet; 1982 Mar 20; 1(8273):643-7. PubMed ID: 6121964 [Abstract] [Full Text] [Related]
26. Wilson's disease: a 1984 perspective. Ede RJ, Mowat AP. Compr Ther; 1984 Dec 20; 10(12):40-7. PubMed ID: 6518737 [No Abstract] [Full Text] [Related]
27. Management of penicillamine nephropathy in Wilson's disease: a new chelating agent. Walshe JM. Lancet; 1969 Dec 27; 2(7635):1401-2. PubMed ID: 4188283 [No Abstract] [Full Text] [Related]
28. Treatment of Wilson's disease with zinc. XVIII. Initial treatment of the hepatic decompensation presentation with trientine and zinc. Askari FK, Greenson J, Dick RD, Johnson VD, Brewer GJ. J Lab Clin Med; 2003 Dec 27; 142(6):385-90. PubMed ID: 14713890 [Abstract] [Full Text] [Related]
29. Wilson's disease, an end to the search for new therapy? May PM, Jones DC, Williams DR. Lancet; 1982 May 15; 1(8281):1127. PubMed ID: 6122924 [No Abstract] [Full Text] [Related]
30. Hypothyroidism and dyshormonogenesis induced by D-penicillamine in children with Wilson's disease and healthy infants born to a mother with Wilson's disease. Hanukoglu A, Curiel B, Berkowitz D, Levine A, Sack J, Lorberboym M. J Pediatr; 2008 Dec 15; 153(6):864-6. PubMed ID: 19014823 [Abstract] [Full Text] [Related]
31. [New possibilities in the treatment of Wilson-Konovalov disease (hepatolenticular degeneration)]. Kolarski V. Vutr Boles; 1987 Dec 15; 26(5):37-40. PubMed ID: 3433729 [Abstract] [Full Text] [Related]
32. [On hepatolenticular degeneration (Wilson's disease). II. Treatment of 2 cases of Wilson's disease for 8 months with D-penicillamine]. Germinario L, Campanella G, D'Addabbo A. Acta Neurol (Napoli); 1971 Dec 15; 26(4):423-35. PubMed ID: 5132824 [No Abstract] [Full Text] [Related]
33. Penicillamine-induced arthropathy in Wilson's disease. Walshe JM, Golding DN. Proc R Soc Med; 1977 Dec 15; 70 Suppl 3(Suppl 3):4-6. PubMed ID: 122670 [No Abstract] [Full Text] [Related]
34. [Wilson's disease (hepatolenticular degeneration)]. Dalmau Obrador J, Martí-Vilalta JL, Aguilar Barberá M. Med Clin (Barc); 1984 Jun 09; 83(2):78-85. PubMed ID: 6381924 [No Abstract] [Full Text] [Related]
35. [Pemphigus in a patient treated with penicillamine for Wilson's disease]. Degos R, Touraine R, Belaïch S, Revuz J. Bull Soc Fr Dermatol Syphiligr; 1969 Jun 09; 76(6):751-3. PubMed ID: 5384189 [No Abstract] [Full Text] [Related]